English
简体中文
Total: £ 56.28
Published Date: 2025-06-17 | Pages: 144 | Tables: 159 | Pharma & Healthcare
In 2024, the global market size of Budesonide was estimated to be worth US$ 8732 million and is forecast to reach approximately US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn"s disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.
The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Budesonide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Budesonide.
The Budesonide market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Budesonide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Budesonide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
AstraZeneca
Teva
Mylan
Sandoz
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod
Segment by Type
Injectable Suspension
Aerosols
Inhalation Powder
Tablet and Capsule
Segment by Application
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Budesonide in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Budesonide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Budesonide sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Budesonide Product Introduction
1.2 Market by Type
1.2.1 Global Budesonide Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Injectable Suspension
1.2.3 Aerosols
1.2.4 Inhalation Powder
1.2.5 Tablet and Capsule
1.3 Market by Application
1.3.1 Global Budesonide Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Respiratory Disease Treatment
1.3.3 Nose Disease Treatment
1.3.4 Inflammatory Bowel Disease Treatment
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Budesonide Market Size Estimates and Forecasts
2.1.1 Global Budesonide Revenue 2020-2031
2.1.2 Global Budesonide Sales 2020-2031
2.2 Budesonide Market Size by Region: 2024 Versus 2031
2.3 Budesonide Sales by Region (2020-2031)
2.3.1 Global Budesonide Sales by Region: 2020-2025
2.3.2 Global Budesonide Sales Forecast by Region (2026-2031)
2.3.3 Global Budesonide Sales Market Share by Region (2020-2031)
2.4 Budesonide Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Budesonide Revenue by Region: 2020-2025
2.4.2 Global Budesonide Revenue Forecast by Region (2026-2031)
2.4.3 Global Budesonide Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Budesonide Sales by Type (2020-2031)
3.1.1.1 Global Budesonide Sales Volume by Type (2020-2031)
3.1.1.2 Global Budesonide Sales Market Share by Type (2020-2031)
3.1.2 Global Budesonide Revenue by Type (2020-2031)
3.1.2.1 Global Budesonide Revenue by Type (2020-2031)
3.1.2.2 Global Budesonide Revenue Market Share by Type (2020-2031)
3.1.3 Budesonide Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Budesonide Sales by Application (2020-2031)
3.2.1.1 Global Budesonide Sales Volume by Application (2020-2031)
3.2.1.2 Global Budesonide Sales Market Share by Application (2020-2031)
3.2.2 Global Budesonide Revenue by Application (2020-2031)
3.2.2.1 Global Budesonide Revenue by Application (2020-2031)
3.2.2.2 Global Budesonide Revenue Market Share by Application (2020-2031)
3.2.3 Budesonide Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Injectable Suspension of Budesonide Revenue Market Share by Application
3.3.2 Aerosols of Budesonide Revenue Market Share by Application
3.3.3 Inhalation Powder of Budesonide Revenue Market Share by Application
3.3.4 Tablet and Capsule of Budesonide Revenue Market Share by Application
4 Global Budesonide by Manufacturers
4.1 Global Top Budesonide Manufacturers by Sales (2020-2025)
4.1.1 Global Budesonide Sales by Manufacturer (2020-2025)
4.1.2 Global Budesonide Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Budesonide Manufacturers by Revenue (2020-2025)
4.2.1 Global Budesonide Revenue by Manufacturer (2020-2025)
4.2.2 Global Budesonide Revenue Share by Manufacturer (2020-2025)
4.3 Global Budesonide Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Budesonide Manufacturers Covered: Ranking by Revenue
4.4.2 Global Budesonide Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Budesonide Manufacturing Base Distribution, Product Type
4.5.1 Budesonide Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Budesonide Market
4.5.3 Manufacturers Budesonide Product Type and Application
4.5.4 Injectable Suspension Market Sales of Budesonide by Manufacturer
4.5.5 Aerosols Market Sales of Budesonide by Manufacturer
4.5.6 Inhalation Powder Market Sales of Budesonide by Manufacturer
4.5.7 Tablet and Capsule Market Sales of Budesonide by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 AstraZeneca
5.1.1 AstraZeneca Company Information
5.1.2 AstraZeneca Description, Business Overview
5.1.3 AstraZeneca Budesonide Products Offered
5.1.4 AstraZeneca Budesonide Sales, Revenue and Gross Margin (2020-2025)
5.1.5 AstraZeneca Budesonide Sales by Product in 2024
5.1.6 AstraZeneca Budesonide Sales by Application in 2024
5.1.7 AstraZeneca Budesonide Sales by Geographic Area in 2024
5.1.8 AstraZeneca Recent Developments
5.2 Teva
5.2.1 Teva Company Information
5.2.2 Teva Description, Business Overview
5.2.3 Teva Budesonide Products Offered
5.2.4 Teva Budesonide Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Teva Budesonide Sales by Product in 2024
5.2.6 Teva Budesonide Sales by Application in 2024
5.2.7 Teva Budesonide Sales by Geographic Area in 2024
5.2.8 Teva Recent Developments
5.3 Mylan
5.3.1 Mylan Company Information
5.3.2 Mylan Description, Business Overview
5.3.3 Mylan Budesonide Products Offered
5.3.4 Mylan Budesonide Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Mylan Budesonide Sales by Product in 2024
5.3.6 Mylan Budesonide Sales by Application in 2024
5.3.7 Mylan Budesonide Sales by Geographic Area in 2024
5.3.8 Mylan Recent Developments
5.4 Sandoz
5.4.1 Sandoz Company Information
5.4.2 Sandoz Description, Business Overview
5.4.3 Sandoz Budesonide Products Offered
5.4.4 Sandoz Budesonide Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Sandoz Budesonide Sales by Product in 2024
5.4.6 Sandoz Budesonide Sales by Application in 2024
5.4.7 Sandoz Budesonide Sales by Geographic Area in 2024
5.4.8 Sandoz Recent Developments
5.5 Cosmo Pharmaceuticals
5.5.1 Cosmo Pharmaceuticals Company Information
5.5.2 Cosmo Pharmaceuticals Description, Business Overview
5.5.3 Cosmo Pharmaceuticals Budesonide Products Offered
5.5.4 Cosmo Pharmaceuticals Budesonide Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Cosmo Pharmaceuticals Budesonide Sales by Product in 2024
5.5.6 Cosmo Pharmaceuticals Budesonide Sales by Application in 2024
5.5.7 Cosmo Pharmaceuticals Budesonide Sales by Geographic Area in 2024
5.5.8 Cosmo Pharmaceuticals Recent Developments
5.6 Salix
5.6.1 Salix Company Information
5.6.2 Salix Description, Business Overview
5.6.3 Salix Budesonide Products Offered
5.6.4 Salix Budesonide Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Salix Budesonide Sales by Product in 2024
5.6.6 Salix Budesonide Sales by Application in 2024
5.6.7 Salix Budesonide Sales by Geographic Area in 2024
5.6.8 Salix Recent Developments
5.7 Chiesi Farmaceutici
5.7.1 Chiesi Farmaceutici Company Information
5.7.2 Chiesi Farmaceutici Description, Business Overview
5.7.3 Chiesi Farmaceutici Budesonide Products Offered
5.7.4 Chiesi Farmaceutici Budesonide Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Chiesi Farmaceutici Budesonide Sales by Product in 2024
5.7.6 Chiesi Farmaceutici Budesonide Sales by Application in 2024
5.7.7 Chiesi Farmaceutici Budesonide Sales by Geographic Area in 2024
5.7.8 Chiesi Farmaceutici Recent Developments
5.8 Orion Corporation
5.8.1 Orion Corporation Company Information
5.8.2 Orion Corporation Description, Business Overview
5.8.3 Orion Corporation Budesonide Products Offered
5.8.4 Orion Corporation Budesonide Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Orion Corporation Budesonide Sales by Product in 2024
5.8.6 Orion Corporation Budesonide Sales by Application in 2024
5.8.7 Orion Corporation Budesonide Sales by Geographic Area in 2024
5.8.8 Orion Corporation Recent Developments
5.9 Cipla
5.9.1 Cipla Company Information
5.9.2 Cipla Description, Business Overview
5.9.3 Cipla Budesonide Products Offered
5.9.4 Cipla Budesonide Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Cipla Budesonide Sales by Product in 2024
5.9.6 Cipla Budesonide Sales by Application in 2024
5.9.7 Cipla Budesonide Sales by Geographic Area in 2024
5.9.8 Cipla Recent Developments
5.10 Synmosa Biopharma
5.10.1 Synmosa Biopharma Company Information
5.10.2 Synmosa Biopharma Description, Business Overview
5.10.3 Synmosa Biopharma Budesonide Products Offered
5.10.4 Synmosa Biopharma Budesonide Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Synmosa Biopharma Budesonide Sales by Product in 2024
5.10.6 Synmosa Biopharma Budesonide Sales by Application in 2024
5.10.7 Synmosa Biopharma Budesonide Sales by Geographic Area in 2024
5.10.8 Synmosa Biopharma Recent Developments
5.11 Lunan Better Pharma
5.11.1 Lunan Better Pharma Company Information
5.11.2 Lunan Better Pharma Description, Business Overview
5.11.3 Lunan Better Pharma Budesonide Products Offered
5.11.4 Lunan Better Pharma Budesonide Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Lunan Better Pharma Budesonide Sales by Product in 2024
5.11.6 Lunan Better Pharma Budesonide Sales by Application in 2024
5.11.7 Lunan Better Pharma Budesonide Sales by Geographic Area in 2024
5.11.8 Lunan Better Pharma Recent Developments
5.12 Shanghai Sine Promod
5.12.1 Shanghai Sine Promod Company Information
5.12.2 Shanghai Sine Promod Description, Business Overview
5.12.3 Shanghai Sine Promod Budesonide Products Offered
5.12.4 Shanghai Sine Promod Budesonide Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Shanghai Sine Promod Budesonide Sales by Product in 2024
5.12.6 Shanghai Sine Promod Budesonide Sales by Application in 2024
5.12.7 Shanghai Sine Promod Budesonide Sales by Geographic Area in 2024
5.12.8 Shanghai Sine Promod Recent Developments
6 North America
6.1 North America Budesonide Market Size YoY Growth 2020-2031
6.2 North America Budesonide Market Facts & Figures by Country
6.2.1 North America Budesonide Sales by Country (2020-2031)
6.2.2 North America Budesonide Revenue by Country (2020-2031)
6.3 North America Budesonide Sales by Type (2020-2025)
6.4 North America Budesonide Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Budesonide Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Budesonide Market Facts & Figures by Region
7.2.1 Asia-Pacific Budesonide Sales by Region (2020-2031)
7.2.2 Asia-Pacific Budesonide Revenue by Region (2020-2031)
7.3 Asia-Pacific Budesonide Sales by Type (2020-2025)
7.4 Asia-Pacific Budesonide Sales by Application (2020-2025)
8 Europe
8.1 Europe Budesonide Market Size YoY Growth 2020-2031
8.2 Europe Budesonide Market Facts & Figures by Country
8.2.1 Europe Budesonide Sales by Country (2020-2031)
8.2.2 Europe Budesonide Revenue by Country (2020-2031)
8.3 Europe Budesonide Sales by Type (2020-2025)
8.4 Europe Budesonide Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Budesonide Market Size YoY Growth 2020-2031
9.2 Latin America Budesonide Market Facts & Figures by Country
9.2.1 Latin America Budesonide Sales by Country (2020-2031)
9.2.2 Latin America Budesonide Revenue by Country (2020-2031)
9.3 Latin America Budesonide Sales by Type (2020-2025)
9.4 Latin America Budesonide Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Budesonide Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Budesonide Market Facts & Figures by Country
10.2.1 Middle East and Africa Budesonide Sales by Country (2020-2031)
10.2.2 Middle East and Africa Budesonide Revenue by Country (2020-2031)
10.3 Middle East and Africa Budesonide Sales by Type (2020-2025)
10.4 Middle East and Africa Budesonide Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Budesonide Supply Chain Analysis
11.2 Budesonide Key Raw Materials and Upstream Suppliers
11.3 Budesonide Clients Analysis
11.4 Budesonide Sales Channel and Sales Model Analysis
11.4.1 Budesonide Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Budesonide Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Budesonide Distributors
12 Budesonide Market Dynamics
12.1 Budesonide Industry Trends
12.2 Budesonide Market Drivers
12.3 Budesonide Market Challenges
12.4 Budesonide Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Budesonide Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Budesonide Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Budesonide Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Budesonide Sales by Region (2020-2025) & (M Units)
Table 5. Global Budesonide Sales Forecast by Region (2026-2031) & (M Units)
Table 6. Global Budesonide Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Budesonide Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Budesonide Sales Volume by Type (2020-2025) & (M Units)
Table 9. Global Budesonide Sales Volume by Type (2026-2031) & (M Units)
Table 10. Global Budesonide Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Budesonide Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Budesonide Sales Volume by Application (2020-2025) & (M Units)
Table 13. Global Budesonide Sales Volume by Application (2026-2031) & (M Units)
Table 14. Global Budesonide Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Budesonide Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Budesonide Sales by Manufacturer (2020-2025) & (M Units)
Table 17. Global Budesonide Sales Share by Manufacturer (2020-2025)
Table 18. Budesonide Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Budesonide Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Budesonide Price (2020-2025) & (USD/K Units)
Table 21. Ranking of Global Top Budesonide Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Budesonide Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Budesonide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Budesonide as of 2024)
Table 24. Budesonide Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Budesonide Market
Table 26. Manufacturers Budesonide Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. AstraZeneca Company Information
Table 29. AstraZeneca Description and Business Overview
Table 30. AstraZeneca Budesonide Product
Table 31. AstraZeneca Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 32. AstraZeneca Sales Proportion of Budesonide by Product in 2024
Table 33. AstraZeneca Sales Proportion of Budesonide by Application in 2024
Table 34. AstraZeneca Sales Proportion of Budesonide by Geographic Area in 2024
Table 35. AstraZeneca Recent Developments
Table 36. Teva Company Information
Table 37. Teva Description and Business Overview
Table 38. Teva Budesonide Product
Table 39. Teva Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 40. Teva Sales Proportion of Budesonide by Product in 2024
Table 41. Teva Sales Proportion of Budesonide by Application in 2024
Table 42. Teva Sales Proportion of Budesonide by Geographic Area in 2024
Table 43. Teva Recent Developments
Table 44. Mylan Company Information
Table 45. Mylan Description and Business Overview
Table 46. Mylan Budesonide Product
Table 47. Mylan Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 48. Mylan Sales Proportion of Budesonide by Product in 2024
Table 49. Mylan Sales Proportion of Budesonide by Application in 2024
Table 50. Mylan Sales Proportion of Budesonide by Geographic Area in 2024
Table 51. Mylan Recent Developments
Table 52. Sandoz Company Information
Table 53. Sandoz Description and Business Overview
Table 54. Sandoz Budesonide Product
Table 55. Sandoz Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 56. Sandoz Sales Proportion of Budesonide by Product in 2024
Table 57. Sandoz Sales Proportion of Budesonide by Application in 2024
Table 58. Sandoz Sales Proportion of Budesonide by Geographic Area in 2024
Table 59. Sandoz Recent Developments
Table 60. Cosmo Pharmaceuticals Company Information
Table 61. Cosmo Pharmaceuticals Description and Business Overview
Table 62. Cosmo Pharmaceuticals Budesonide Product
Table 63. Cosmo Pharmaceuticals Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 64. Cosmo Pharmaceuticals Sales Proportion of Budesonide by Product in 2024
Table 65. Cosmo Pharmaceuticals Sales Proportion of Budesonide by Application in 2024
Table 66. Cosmo Pharmaceuticals Sales Proportion of Budesonide by Geographic Area in 2024
Table 67. Cosmo Pharmaceuticals Recent Developments
Table 68. Salix Company Information
Table 69. Salix Description and Business Overview
Table 70. Salix Budesonide Product
Table 71. Salix Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 72. Salix Sales Proportion of Budesonide by Product in 2024
Table 73. Salix Sales Proportion of Budesonide by Application in 2024
Table 74. Salix Sales Proportion of Budesonide by Geographic Area in 2024
Table 75. Salix Recent Developments
Table 76. Chiesi Farmaceutici Company Information
Table 77. Chiesi Farmaceutici Description and Business Overview
Table 78. Chiesi Farmaceutici Budesonide Product
Table 79. Chiesi Farmaceutici Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 80. Chiesi Farmaceutici Sales Proportion of Budesonide by Product in 2024
Table 81. Chiesi Farmaceutici Sales Proportion of Budesonide by Application in 2024
Table 82. Chiesi Farmaceutici Sales Proportion of Budesonide by Geographic Area in 2024
Table 83. Chiesi Farmaceutici Recent Developments
Table 84. Orion Corporation Company Information
Table 85. Orion Corporation Description and Business Overview
Table 86. Orion Corporation Budesonide Product
Table 87. Orion Corporation Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 88. Orion Corporation Sales Proportion of Budesonide by Product in 2024
Table 89. Orion Corporation Sales Proportion of Budesonide by Application in 2024
Table 90. Orion Corporation Sales Proportion of Budesonide by Geographic Area in 2024
Table 91. Orion Corporation Recent Developments
Table 92. Cipla Company Information
Table 93. Cipla Description and Business Overview
Table 94. Cipla Budesonide Product
Table 95. Cipla Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 96. Cipla Sales Proportion of Budesonide by Product in 2024
Table 97. Cipla Sales Proportion of Budesonide by Application in 2024
Table 98. Cipla Sales Proportion of Budesonide by Geographic Area in 2024
Table 99. Cipla Recent Developments
Table 100. Synmosa Biopharma Company Information
Table 101. Synmosa Biopharma Description and Business Overview
Table 102. Synmosa Biopharma Budesonide Product
Table 103. Synmosa Biopharma Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 104. Synmosa Biopharma Sales Proportion of Budesonide by Product in 2024
Table 105. Synmosa Biopharma Sales Proportion of Budesonide by Application in 2024
Table 106. Synmosa Biopharma Sales Proportion of Budesonide by Geographic Area in 2024
Table 107. Synmosa Biopharma Recent Developments
Table 108. Lunan Better Pharma Company Information
Table 109. Lunan Better Pharma Description and Business Overview
Table 110. Lunan Better Pharma Budesonide Product
Table 111. Lunan Better Pharma Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 112. Lunan Better Pharma Sales Proportion of Budesonide by Product in 2024
Table 113. Lunan Better Pharma Sales Proportion of Budesonide by Application in 2024
Table 114. Lunan Better Pharma Sales Proportion of Budesonide by Geographic Area in 2024
Table 115. Lunan Better Pharma Recent Developments
Table 116. Shanghai Sine Promod Company Information
Table 117. Shanghai Sine Promod Description and Business Overview
Table 118. Shanghai Sine Promod Budesonide Product
Table 119. Shanghai Sine Promod Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 120. Shanghai Sine Promod Sales Proportion of Budesonide by Product in 2024
Table 121. Shanghai Sine Promod Sales Proportion of Budesonide by Application in 2024
Table 122. Shanghai Sine Promod Sales Proportion of Budesonide by Geographic Area in 2024
Table 123. Shanghai Sine Promod Recent Developments
Table 124. North America Budesonide Sales by Country (2020-2025) & (M Units)
Table 125. North America Budesonide Sales by Country (2026-2031) & (M Units)
Table 126. North America Budesonide Revenue by Country (2020-2025) & (US$ Million)
Table 127. North America Budesonide Revenue by Country (2026-2031) & (US$ Million)
Table 128. North America Budesonide Sales by Type (2020-2025) & (M Units)
Table 129. North America Budesonide Sales by Application (2020-2025) & (M Units)
Table 130. Asia-Pacific Budesonide Sales by Region (2020-2025) & (M Units)
Table 131. Asia-Pacific Budesonide Sales by Region (2026-2031) & (M Units)
Table 132. Asia-Pacific Budesonide Revenue by Region (2020-2025) & (US$ Million)
Table 133. Asia-Pacific Budesonide Revenue by Region (2026-2031) & (US$ Million)
Table 134. Asia-Pacific Budesonide Sales by Type (2020-2025) & (M Units)
Table 135. Asia-Pacific Budesonide Sales by Application (2020-2025) & (M Units)
Table 136. Europe Budesonide Sales by Country (2020-2025) & (M Units)
Table 137. Europe Budesonide Sales by Country (2026-2031) & (M Units)
Table 138. Europe Budesonide Revenue by Country (2020-2025) & (US$ Million)
Table 139. Europe Budesonide Revenue by Country (2026-2031) & (US$ Million)
Table 140. Europe Budesonide Sales by Type (2020-2025) & (M Units)
Table 141. Europe Budesonide Sales by Application (2020-2025) & (M Units)
Table 142. Latin America Budesonide Sales by Country (2020-2025) & (M Units)
Table 143. Latin America Budesonide Sales by Country (2026-2031) & (M Units)
Table 144. Latin America Budesonide Revenue by Country (2020-2025) & (US$ Million)
Table 145. Latin America Budesonide Revenue by Country (2026-2031) & (US$ Million)
Table 146. Latin America Budesonide Sales by Type (2020-2025) & (M Units)
Table 147. Latin America Budesonide Sales by Application (2020-2025) & (M Units)
Table 148. Middle East and Africa Budesonide Sales by Country (2020-2025) & (M Units)
Table 149. Middle East and Africa Budesonide Sales by Country (2026-2031) & (M Units)
Table 150. Middle East and Africa Budesonide Revenue by Country (2020-2025) & (US$ Million)
Table 151. Middle East and Africa Budesonide Revenue by Country (2026-2031) & (US$ Million)
Table 152. Middle East and Africa Budesonide Sales by Type (2020-2025) & (M Units)
Table 153. Middle East and Africa Budesonide Sales by Application (2020-2025) & (M Units)
Table 154. Budesonide Key Raw Materials, Industry Status and Trend
Table 155. Budesonide Key Raw Materials and Upstream Suppliers
Table 156. Budesonide Clients Status and Trend
Table 157. Budesonide Typical Clients
Table 158. Budesonide Distributors
Table 159. Budesonide Market Trends
Table 160. Budesonide Market Drivers
Table 161. Budesonide Market Challenges
Table 162. Budesonide Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Budesonide Product Picture
Figure 2. Global Budesonide Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Budesonide Sales Market Share by Type in 2024 & 2031
Figure 4. Injectable Suspension Product Picture
Figure 5. Aerosols Product Picture
Figure 6. Inhalation Powder Product Picture
Figure 7. Tablet and Capsule Product Picture
Figure 8. Global Budesonide Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Budesonide Sales Market Share by Application in 2024 & 2031
Figure 10. Respiratory Disease Treatment
Figure 11. Nose Disease Treatment
Figure 12. Inflammatory Bowel Disease Treatment
Figure 13. Others
Figure 14. Budesonide Report Years Considered
Figure 15. Global Budesonide Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Budesonide Market Size 2020-2031 (US$ Million)
Figure 17. Global Budesonide Sales 2020-2031 (M Units)
Figure 18. Global Budesonide Sales Market Share Forecast by Region (2020-2031)
Figure 19. Global Budesonide Revenue Market Share by Region (2020-2031)
Figure 20. Global Budesonide Sales Market Share Forecast by Type (2020-2031)
Figure 21. Global Budesonide Revenue Market Share Forecast by Type (2020-2031)
Figure 22. Budesonide Average Selling Price (ASP) by Type (2020-2025) & (USD/K Units)
Figure 23. Global Budesonide Sales Market Share Forecast by Application (2020-2031)
Figure 24. Global Budesonide Revenue Market Share Forecast by Application (2020-2031)
Figure 25. Budesonide Average Selling Price (ASP) by Application (2020-2025) & (USD/K Units)
Figure 26. Injectable Suspension of Budesonide Revenue Market Share by Application, 2024 VS 2031
Figure 27. Aerosols of Budesonide Revenue Market Share by Application, 2024 VS 2031
Figure 28. Inhalation Powder of Budesonide Revenue Market Share by Application, 2024 VS 2031
Figure 29. Tablet and Capsule of Budesonide Revenue Market Share by Application, 2024 VS 2031
Figure 30. Global Budesonide Sales Share by Manufacturer in 2024
Figure 31. Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 32. Injectable Suspension Market Sales Proportion by Manufacturer in 2024
Figure 33. Aerosols Market Sales Proportion by Manufacturer in 2024
Figure 34. Inhalation Powder Market Sales Proportion by Manufacturer in 2024
Figure 35. Tablet and Capsule Market Sales Proportion by Manufacturer in 2024
Figure 36. North America Budesonide Revenue 2020-2031 (US$ Million)
Figure 37. North America Budesonide Sales Market Share by Type (2020-2025)
Figure 38. North America Budesonide Sales Market Share by Application (2020-2025)
Figure 39. Asia-Pacific Budesonide Revenue 2020-2031 (US$ Million)
Figure 40. Asia-Pacific Budesonide Sales Market Share by Region (2020-2031)
Figure 41. Asia-Pacific Budesonide Revenue Market Share by Region (2020-2031)
Figure 42. Asia-Pacific Budesonide Sales Market Share by Type (2020-2025)
Figure 43. Asia-Pacific Budesonide Sales Market Share by Application (2020-2025)
Figure 44. Europe Budesonide Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Europe Budesonide Sales Market Share by Country (2020-2031)
Figure 46. Europe Budesonide Revenue Market Share by Country (2020-2031)
Figure 47. Europe Budesonide Sales Market Share by Type (2020-2025)
Figure 48. Europe Budesonide Sales Market Share by Application (2020-2025)
Figure 49. Latin America Budesonide Revenue Growth Rate 2020-2031 (US$ Million)
Figure 50. Latin America Budesonide Sales Market Share by Country (2020-2031)
Figure 51. Latin America Budesonide Revenue Market Share by Country (2020-2025)
Figure 52. Latin America Budesonide Sales Market Share by Type (2020-2025)
Figure 53. Latin America Budesonide Sales Market Share by Application (2020-2025)
Figure 54. Middle East and Africa Budesonide Revenue Growth Rate 2020-2031 (US$ Million)
Figure 55. Middle East and Africa Budesonide Sales Market Share by Country (2020-2031)
Figure 56. Middle East and Africa Budesonide Revenue Market Share by Country (2020-2031)
Figure 57. Middle East and Africa Budesonide Sales Market Share by Type (2020-2025)
Figure 58. Middle East and Africa Budesonide Sales Market Share by Application (2020-2025)
Figure 59. Budesonide Supply Chain (Upstream and Downstream Market)
Figure 60. Global Production Market Share of Budesonide Raw Materials by Region in 2024
Figure 61. Budesonide Distribution Channels
Figure 62. Global Budesonide Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 63. Global Budesonide Percentage 2020-2031: Online Sales VS Offline Sales
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
